Education

Universitätsmedizin Magdeburg/Christian Morawe

Through partnership, our team of experts will support physicians and their teams from system integration to procedure adoption and program development. Together, our investment in this partnership will help the organization realize the full potential of the technology.

Our Education Strategy

The HistoSonics education strategy delivers on the following four priorities:

1. Education beyond the proceduralist and procedure

2. Multifaceted education portfolio

Circle with three horizontal diamonds icon

3. Shared ownership through partnership

4. Focus on clinical excellence & procedure adoption

View Our Map 2 Mastery

Our comprehensive education model is a longitudinal series of education and implementation activities focused on the learner pathway.

Phase 1

Phase 2

Phase 3

Technology Training

Introduction to Histotripsy
Patient Selection Exercise
Planning & Procedure Simulation

Procedure Training

Procedure Staff Training
Fellows Training
Mock Procedure
Initial Case Support

Procedure Optimization

Procedure Support (live & virtual)
Learning Curve Assessment
Case review
Optimization Training/Best Practice Review

Portfolio of Education Programs & Services

Central to the HistoSonics Education Strategy is a commitment to clinical excellence and procedure adoption. Our education programming and services are designed to provide innovative education solutions to move the learner from novice to master in the delivery of histotripsy therapy.

Technology & Procedure Training

- Map to Mastery Model
- Planning & Procedure Simulations
- HistoSonics Learning Center Events

Awareness Education Programs

- Multi-D Introduction to Histotripsy
- Society Partner Events
- Fellows Programming

Regional Education Network

- Regional Education Events
- Access to Histotripsy Experts
- Procedure Staff Network
- Best Practice Sharing

Education Support Services

- Clinical/Technical Case Support
- Clinical Immersions, Case Observations
- Tumor Board, Grand Rounds Support
- Implementation Support

Resources

Take a Deeper Dive

“Making the Impossible
Possible.”

Dr. Zhen Xu, PhD
University of Michigan

Video | 2:26

A Surgeon’s Perspective on Histotripsy

Joan Vidal-Jové, MD. PhD.
THERESA Study Clinical Investigator

Video | 3:34

How Histotripsy Works

Dr. Cliff Cho MD.
University of Michigan

Video | 1:36

Our team is bringing the power of histotripsy to patients and physicians around the world.

Meet The Team

Last updated on February 20, 2024

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics Inc., and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on March 3, 2025